SCOPUS 정보 검색 플랫폼

Volumn 83, Issue 5, 2011, Pages 1623-1633

Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers

(10) De Beer, T R M a Wiggenhorn, M b Hawe, A c Kasper, J C b Almeida, A a Quinten, T a Friess, W b Winter, G b Vervaet, C a Remon, J P a

a GHENT UNIVERSITY (Belgium)

b UNIVERSITY OF MUNICH (Germany)

c LEIDEN UNIVERSITY (Netherlands)

Author keywords

Design space; Freeze drying; Optimisation; Spectroscopy

Indexed keywords

ANNEALING; BEER; DESIGN OF EXPERIMENTS; DRUG PRODUCTS; EMISSION SPECTROSCOPY; FREEZING; HYDRATES; HYDRATION; INFRARED DEVICES; INTELLIGENT SYSTEMS; LOW TEMPERATURE DRYING; MOISTURE; MOISTURE DETERMINATION; MONTE CARLO METHODS; NEAR INFRARED SPECTROSCOPY; POLYOLS; PROCESS DESIGN; PRODUCT DESIGN; SODIUM CHLORIDE; SPECTROSCOPY; X RAY POWDER DIFFRACTION;

DESIGN SPACES; EXPERIMENTAL DESIGN APPROACHES; FRACTIONAL FACTORIAL DESIGNS; FREEZE DRYING; OPTIMISATIONS; PHARMACEUTICAL FORMULATION; PLASMA EMISSION SPECTROSCOPY; RESIDUAL MOISTURE CONTENT;

DRYING;

EID: 78751567941 PISSN: 00399140 EISSN: None Source Type: Journal
DOI: 10.1016/j.talanta.2010.11.051 Document Type: Article

Times cited : (42)

References (18)

1
- 14844291495
- U.S. Food and Drug Administration, September
- Guidance for Industry: PAT - a Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, U.S. Food and Drug Administration, September 2004 (http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070305.pdf ).
- (2004) Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance

2
- 33750065701
- A. Hawe, and W. Friess Eur. J. Pharm. Biopharm. 64 2006 316 325
- (2006) Eur. J. Pharm. Biopharm. , vol.64 , pp. 316-325
- Hawe, A.¹ Friess, W.²

3
- 37849025164
- A. Hawe, and W. Friess Eur. J. Pharm. Biopharm. 68 2008 169 182
- (2008) Eur. J. Pharm. Biopharm. , vol.68 , pp. 169-182
- Hawe, A.¹ Friess, W.²

4
- 70349146702
- T.R.M. De Beer, M. Wiggenhorn, R. Veillon, C. Debacq, Y. Mayeresse, B. Moreau, A. Burggraeve, T. Quinten, W. Friess, G. Winter, C. Vervaet, J.P. Remon, and W.R.G. Baeyens Anal. Chem. 81 2009 7639 7649
- (2009) Anal. Chem. , vol.81 , pp. 7639-7649
- De Beer, T.R.M.¹ Wiggenhorn, M.² Veillon, R.³ Debacq, C.⁴ Mayeresse, Y.⁵ Moreau, B.⁶ Burggraeve, A.⁷ Quinten, T.⁸ Friess, W.⁹ Winter, G.¹⁰ Vervaet, C.¹¹ Remon, J.P.¹² Baeyens, W.R.G.¹³

5
- 76749142425
- K. Naelapää, P. Veski, H.G. Kristensen, J. Rantanen, and P. Bertelsen Pharm. Dev. Technol. 15 2010 35 45
- (2010) Pharm. Dev. Technol. , vol.15 , pp. 35-45
- Naelapää, K.¹ Veski, P.² Kristensen, H.G.³ Rantanen, J.⁴ Bertelsen, P.⁵

6
- 70449336722
- S.M. Patel, and M. Pikal Pharm. Dev. Technol. 14 2009 567 587
- (2009) Pharm. Dev. Technol. , vol.14 , pp. 567-587
- Patel, S.M.¹ Pikal, M.²

7
- 34547770734
- Y. Mayeresse, P.H. Sibille, and C. Nomine PDA J. Pharm. Sci. Technol. 61 2007 160 174
- (2007) PDA J. Pharm. Sci. Technol. , vol.61 , pp. 160-174
- Mayeresse, Y.¹ Sibille, P.H.² Nomine, C.³

8
- 68949142802
- T.R.M. De Beer, P. Vercruysse, A. Burggraeve, T. Quinten, J. Ouyang, X. Zhang, C. Vervaet, J.P. Remon, and W.R.G. Baeyens J. Pharm. Sci. 98 2009 3430 3446
- (2009) J. Pharm. Sci. , vol.98 , pp. 3430-3446
- De Beer, T.R.M.¹ Vercruysse, P.² Burggraeve, A.³ Quinten, T.⁴ Ouyang, J.⁵ Zhang, X.⁶ Vervaet, C.⁷ Remon, J.P.⁸ Baeyens, W.R.G.⁹

9
- 27944460835
- M.J. Pikal J. Swarbrick, Encyclopedia of Pharmaceutical Technology 2002 Marcel Dekker New York 1807 1833
- (2002) Encyclopedia of Pharmaceutical Technology , pp. 1807-1833
- Pikal, M.J.¹

10
- 0036285548
- R. Johnson, C. Kirchhoff, and H. Gaud J. Pharm. Sci. 91 2002 914 922
- (2002) J. Pharm. Sci. , vol.91 , pp. 914-922
- Johnson, R.¹ Kirchhoff, C.² Gaud, H.³

11
- 0037335194
- M. Brülls, S. Folestad, A. Sparen, and A. Rasmuson Pharm. Res. 20 2003 494 499
- (2003) Pharm. Res. , vol.20 , pp. 494-499
- Brülls, M.¹ Folestad, S.² Sparen, A.³ Rasmuson, A.⁴

12
- 0034029664
- A. Cannon, and E. Trappler PDA J. Pharm. Sci. Technol. 54 2000 13 22
- (2000) PDA J. Pharm. Sci. Technol. , vol.54 , pp. 13-22
- Cannon, A.¹ Trappler, E.²

13
- 0036288731
- A. Pyne, R. Surana, and R. Suryanararyanan Pharm. Res. 19 2002 901 908
- (2002) Pharm. Res. , vol.19 , pp. 901-908
- Pyne, A.¹ Surana, R.² Suryanararyanan, R.³

14
- 27144435461
- X. Liao, R. Krishnamurthy, and R. Suryanarayanan Pharm. Res. 22 2005 1978 1985
- (2005) Pharm. Res. , vol.22 , pp. 1978-1985
- Liao, X.¹ Krishnamurthy, R.² Suryanarayanan, R.³

15
- 75749132791
- H. Grohganz, M. Fonteyne, E. Skibsted, T. Falck, B. Palmqvist, and J. Rantanen Eur. J. Pharm. Biopharm. 74 2010 406 412
- (2010) Eur. J. Pharm. Biopharm. , vol.74 , pp. 406-412
- Grohganz, H.¹ Fonteyne, M.² Skibsted, E.³ Falck, T.⁴ Palmqvist, B.⁵ Rantanen, J.⁶

16
- 0035089518
- Y. Vander Heyden, A. Nijhuis, J. Smeyers-Verbeke, B.G.M. Vandeginste, and D.L. Massart J. Pharm. Biomed. Anal. 24 2001 723 753
- (2001) J. Pharm. Biomed. Anal. , vol.24 , pp. 723-753
- Vander Heyden, Y.¹ Nijhuis, A.² Smeyers-Verbeke, J.³ Vandeginste, B.G.M.⁴ Massart, D.L.⁵

17
- 35848946390
- T. De Beer, M. Allesø, F. Goethals, A. Coppens, Y. Vander Heyden, H. Lopez De Diego, J. Rantanen, F. Verpoort, C. Vervaet, J.P. Remon, and W.R.G. Baeyens Anal. Chem. 79 2007 7992 8003
- (2007) Anal. Chem. , vol.79 , pp. 7992-8003
- De Beer, T.¹ Allesø, M.² Goethals, F.³ Coppens, A.⁴ Vander Heyden, Y.⁵ Lopez De Diego, H.⁶ Rantanen, J.⁷ Verpoort, F.⁸ Vervaet, C.⁹ Remon, J.P.¹⁰ Baeyens, W.R.G.¹¹

18
- 0003510115
- Umetrics Academy
- L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikström, and S. Wold Design of Experiments: Principles and Applications 2008 Umetrics Academy
- (2008) Design of Experiments: Principles and Applications
- Eriksson, L.¹ Johansson, E.² Kettaneh-Wold, N.³ Wikström, C.⁴ Wold, S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.